InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.28%
)
US TECH 100
19,312.80
(
0.08%
)
Dow Jones
42,124.65
(
0.15%
)
Brent Oil
73.80
(
0.08%
)
Bitcoin
62,893.65
(
-0.68%
)
Post# of 27624
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Katfish

Send PM Follow Ignore
Followers 80
Posts 24706
Boards Moderated 1
Alias Born 09/08/2000

Katfish

Member Level

Re: None

Monday, 01/14/2019 8:03:00 AM

Monday, January 14, 2019 8:03:00 AM

Post# of 27624
VVUS - 3.22 Pre-market now at 3.27/3.40

Data Supporting the Cardiovascular Safety of VIVUS’ Qsymia® Published in The Journal of Clinical Endocrinology & Metabolism

*VIVUS: Study Finds No Increase in Risk for Major Adverse Cardiovascular Events for Individuals Currently Using Phentermine in Combination With Topiramate >VVUS

https://www.stockscores.com/charts/charts/?ticker=vvus
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up